A cautionary tale: Delayed onset rhabdomyolysis due to erythromycin/ simvastatin interaction

Age and Ageing

Volumn 36, Issue 5, 2007, Pages 597-

  Campbell, Ge ^a   Jayakumar, U ^a   McCracken, S ^a   Bene, J ^a  

^a ROYAL BOLTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; ERYTHROMYCIN; SIMVASTATIN;

AGED; ANAMNESIS; ARTICLE; CASE REPORT; HEMOFILTRATION; HOSPITAL ADMISSION; HUMAN; KIDNEY FAILURE; MALE; MYALGIA; MYOGLOBINURIA; PRIORITY JOURNAL; RHABDOMYOLYSIS;

AGED; AGED, 80 AND OVER; DRUG INTERACTIONS; ERYTHROMYCIN; HUMANS; MALE; RHABDOMYOLYSIS; SIMVASTATIN;

EID: 35048848925     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afm110     Document Type: Article

References (3)

1. Bellosta S, Paoletti R, Corsini A. Safety of statins. Focus on clinical pharmacokinetics and drug interactions. Circulation 2004; 109(Suppl. III): III-50-III-57.
2. British National Formulary. 2007; March.
3. Simvastatin: Summary of Product Characteristics. 2006; www.emc.medicines.org.uk.